Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Interobserver agreement in the nuclear grading of primary pulmonary adenocarcinoma.

Nakazato Y, Maeshima AM, Ishikawa Y, Yatabe Y, Fukuoka J, Yokose T, Tomita Y, Minami Y, Asamura H, Tachibana K, Goya T, Noguchi M.

J Thorac Oncol. 2013 Jun;8(6):736-43. doi: 10.1097/JTO.0b013e318288dbd8.

2.

Nuclear grading of primary pulmonary adenocarcinomas: correlation between nuclear size and prognosis.

Nakazato Y, Minami Y, Kobayashi H, Satomi K, Anami Y, Tsuta K, Tanaka R, Okada M, Goya T, Noguchi M.

Cancer. 2010 Apr 15;116(8):2011-9. doi: 10.1002/cncr.24948.

3.
4.

Adenocarcinoma in situ, minimally invasive adenocarcinoma, and invasive pulmonary adenocarcinoma--analysis of interobserver agreement, survival, radiographic characteristics, and gross pathology in 296 nodules.

Boland JM, Froemming AT, Wampfler JA, Maldonado F, Peikert T, Hyland C, de Andrade M, Aubry MC, Yang P, Yi ES.

Hum Pathol. 2016 May;51:41-50. doi: 10.1016/j.humpath.2015.12.010.

PMID:
27067781
5.

The International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society grading system has limited prognostic significance in advanced resected pulmonary adenocarcinoma.

Westaway DD, Toon CW, Farzin M, Sioson L, Watson N, Brady PW, Marshman D, Mathur MM, Gill AJ.

Pathology. 2013 Oct;45(6):553-8. doi: 10.1097/PAT.0b013e32836532ae.

PMID:
24018816
6.

Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.

Yoshizawa A, Motoi N, Riely GJ, Sima CS, Gerald WL, Kris MG, Park BJ, Rusch VW, Travis WD.

Mod Pathol. 2011 May;24(5):653-64. doi: 10.1038/modpathol.2010.232.

7.

[Prognostic significance of a newly proposed grading and scoring system in stage I pulmonary adenocarcinoma].

Ding FG, Liu B, Zhang XH, Xu Y, Yu B, Zhang RS, He Y, Ma HH, Lu ZF, Zhou XJ.

Zhonghua Bing Li Xue Za Zhi. 2012 Mar;41(3):145-50. doi: 10.3760/cma.j.issn.0529-5807.2012.03.001. Chinese.

PMID:
22800475
8.

Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas.

Warth A, Stenzinger A, von Br√ľnneck AC, Goeppert B, Cortis J, Petersen I, Hoffmann H, Schnabel PA, Weichert W.

Eur Respir J. 2012 Nov;40(5):1221-7. doi: 10.1183/09031936.00219211.

9.

Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome.

Wu TT, Chirieac LR, Abraham SC, Krasinskas AM, Wang H, Rashid A, Correa AM, Hofstetter WL, Ajani JA, Swisher SG.

Am J Surg Pathol. 2007 Jan;31(1):58-64.

PMID:
17197919
10.

A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma.

Kadota K, Suzuki K, Kachala SS, Zabor EC, Sima CS, Moreira AL, Yoshizawa A, Riely GJ, Rusch VW, Adusumilli PS, Travis WD.

Mod Pathol. 2012 Aug;25(8):1117-27. doi: 10.1038/modpathol.2012.58.

12.

Modified histologic classification as a prognostic factor in pulmonary adenocarcinoma.

Hwang I, Park KU, Kwon KY.

Int J Surg Pathol. 2014 May;22(3):212-20. doi: 10.1177/1066896914525230.

PMID:
24599899
13.

Histologic grading of invasive lobular carcinoma: does use of a 2-tiered nuclear grading system improve interobserver variability?

Adams AL, Chhieng DC, Bell WC, Winokur T, Hameed O.

Ann Diagn Pathol. 2009 Aug;13(4):223-5. doi: 10.1016/j.anndiagpath.2009.03.004.

PMID:
19608079
14.

Prognostic significance of the IASLC/ATS/ERS classification in Chinese patients-A single institution retrospective study of 292 lung adenocarcinoma.

Gu J, Lu C, Guo J, Chen L, Chu Y, Ji Y, Ge D.

J Surg Oncol. 2013 Apr;107(5):474-80. doi: 10.1002/jso.23259.

PMID:
22952152
15.

Mitosis trumps T stage and proposed international association for the study of lung cancer/american thoracic society/european respiratory society classification for prognostic value in resected stage 1 lung adenocarcinoma.

Duhig EE, Dettrick A, Godbolt DB, Pauli J, van Zwieten A, Hansen AR, Yang IA, Fong KM, Clarke BE, Bowman RV.

J Thorac Oncol. 2015 Apr;10(4):673-81. doi: 10.1097/JTO.0000000000000446.

16.

Micropapillary pattern and grade of stromal invasion in pT1 adenocarcinoma of the lung: usefulness as prognostic factors.

Kawakami T, Nabeshima K, Makimoto Y, Hamasaki M, Iwasaki A, Shirakusa T, Iwasaki H.

Mod Pathol. 2007 May;20(5):514-21.

18.

The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.

Warth A, Muley T, Meister M, Stenzinger A, Thomas M, Schirmacher P, Schnabel PA, Budczies J, Hoffmann H, Weichert W.

J Clin Oncol. 2012 May 1;30(13):1438-46. doi: 10.1200/JCO.2011.37.2185.

PMID:
22393100
19.

Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients.

Sun Y, Yu X, Shi X, Hong W, Zhao J, Shi L.

World J Surg Oncol. 2014 May 19;12:148. doi: 10.1186/1477-7819-12-148.

20.

Prognostic value of the IASLC/ATS/ERS classification of lung adenocarcinoma in stage I disease of Japanese cases.

Woo T, Okudela K, Mitsui H, Tajiri M, Yamamoto T, Rino Y, Ohashi K, Masuda M.

Pathol Int. 2012 Dec;62(12):785-91. doi: 10.1111/pin.12016.

PMID:
23252867
Items per page

Supplemental Content

Support Center